This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This ACSM2A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 41-67 amino acids from the N-terminal region of human ACSM2A.
ACSM2A
Reaktivität: Human
WB, ELISA
Wirt: Kaninchen
Polyclonal
FITC
Applikationshinweise
For WB starting dilution is: 1:1000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.5 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Target
ACSM2A
(Acyl-CoA Synthetase Medium-Chain Family Member 2A (ACSM2A))
A-923A4.1 antikoerper, ACSM2 antikoerper, ACSM2A antikoerper, acyl-CoA synthetase medium chain family member 2A antikoerper, acyl-CoA synthetase medium-chain family member 2B antikoerper, acyl-coenzyme A synthetase ACSM2B, mitochondrial antikoerper, ACSM2A antikoerper, ACSM2B antikoerper, LOC479822 antikoerper
Hintergrund
ACSM2A has medium-chain fatty acid:CoA ligase activity with broad substrate specificity (in vitro). Acts on acids from C(4) to C(11) and on the corresponding 3-hydroxy-and 2,3-or 3,4-unsaturated acids (in vitro) (By similarity).